In a study by Kim et al, which included 396 patients with resected pancreatic cancer, patients with ATM loss tended to have more vascular invasion (63.3%) and lymph node metastasis (92.2%) compared with cases without ATM loss (49.4% and 84.1%, respectively). This evidence concerns the gene ATM and pancreatic neoplasm.